Chronic inflammation has been shown to be a major player in lung cancer (7–10), and a number of studies have been carried out to correlate inflammatory biomarkers such as C-reactive protein (CRP), with the subsequent development of lung cancer (11). The gene discussed is CRP; the disease is lung cancer.